Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
about
Transmissible Spongiform Encephalopathies Affecting HumansTreatment of Prion Disease with Heterologous Prion ProteinsThermodynamic Stabilization of the Folded Domain of Prion Protein Inhibits Prion Infection in VivoSingle treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.RNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected miceMouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs.Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells.Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agentsLentiviral-mediated silencing of farnesyl pyrophosphate synthase through RNA interference in mice.Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.Role of MicroRNA in Visceral Pain.Recent advances in prion chemotherapeutics.The cellular prion protein (PrP(C)): its physiological function and role in diseaseIntracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice.Progress on RNAi-based molecular medicines.Therapeutic approaches for prion disorders.Prion-like propagation of protein aggregation and related therapeutic strategies.Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.Lentiviral delivery of short hairpin RNAsTherapy for prion diseases: Insights from the use of RNA interference.Therapeutic interventions ameliorating prion disease.Antisense gene silencing: therapy for neurodegenerative disorders?Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.RNAi: a potential new class of therapeutic for human genetic disease.Modelling neurodegeneration in prion disease - applications for drug development.Small RNA drugs for prion disease: a new frontier.Review of studies that have used knockout mice to assess normal function of prion protein under immunological or pathophysiological stress.RNA-based drugs and vaccines.Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay.Insights from Therapeutic Studies for PrP Prion Disease.Overexpression of p62/SQSTM1 promotes the degradations of abnormally accumulated PrP mutants in cytoplasm and relieves the associated cytotoxicities via autophagy-lysosome-dependent way.Efficient knockdown of human prnp mRNA expression levels using hybrid hammerhead ribozymes.Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo.RNAi: a novel strategy for the treatment of prion diseases.Dual MicroRNA to Cellular Prion Protein Inhibits Propagation of Pathogenic Prion Protein in Cultured Cells.
P2860
Q24549130-141114B0-7B7D-441E-A32E-3D9754B6268BQ27303161-4B096E18-0650-4E60-A1D2-EF757A096E35Q27679150-D36C950D-EEFC-4A94-84A3-B05DDA9C0AA1Q30482741-3D9E3950-6556-4920-92D6-C14DCA19DEFEQ30540027-A539AC49-C21F-4B24-98ED-1D78B732828FQ31023317-EEB58072-B61D-42B5-BD16-7D4815B4CDC8Q33565464-F7E71472-37DA-4156-9D5F-E9934636E4FCQ33608651-35EA465A-55F4-4A9E-900F-78E2655610E7Q33670676-D4089EBC-016B-4502-A969-7CC59B3B69ACQ33772925-84E67C07-27FE-4CF1-8676-366354AD177CQ34017963-4938067F-B2C0-4379-A8EA-88E7B7B56801Q34036311-B3F7CBCF-585F-459F-82A1-8806C9F6BCD1Q35061631-A9BD28A2-D482-49E6-B4DC-068D9898FFF2Q35194908-6D13E704-D465-4400-83DE-EA4923D15CF0Q35430578-7F1BF968-FAE5-4891-85EA-9F5D80C61ED0Q35944199-8F46DF3E-2138-4A2A-83D9-6D7A104185BCQ36003019-E26B692A-42A3-4B58-B5C8-203326A92A13Q36053816-AD862A6D-A9E3-45BD-9185-405019DE7B8EQ36161380-7893D1AA-8CDC-4175-A7A7-1B5B776FB86AQ36901944-48146D75-0FC6-410C-8A24-4D1AE2FCE947Q36983208-F0E26C98-1FBB-4D2A-86C9-509B78F0C7E8Q37068234-32403BE9-344F-4C9D-9163-3F78B7EA0BB2Q37430557-695F689D-C754-4884-9445-B5ECDC05015CQ37549830-B318D41E-8C0D-4533-BB07-9D9620BBC15FQ37557690-FB28A8B5-99D3-4857-A914-935B5829CBC1Q37585001-E8B6EDB4-1016-4A30-BAA8-23FBAD986ED2Q37791489-F90D2B43-CDC0-4FD5-B15A-518405DE3165Q37812614-EB779939-F601-4576-9EC3-5F689C1116F7Q37871417-81FB8236-D6F7-4A44-B907-A90BC1B6E3ACQ38089150-954FA6FA-923B-4CFA-BB33-F81DB01F5F36Q38121120-31F6AFAE-7E0D-4C47-AADA-ABA98FD6646AQ38215344-7781F1A5-E0A9-4427-B515-B6B3017BE3DEQ38249163-5207A0D8-FED2-4E60-8CFC-E374365B5B61Q38877330-3E43454C-94B2-4567-8728-C42A870F7EAAQ39005891-7E7922C2-3105-46BF-87F6-1475A82941DFQ39062404-70EB6EFD-6960-4522-9613-7C3E9A4E062BQ39810017-7FFF1396-7997-4F2A-A867-C42FFBD5830EQ40100079-CAE34716-CE78-42D7-8431-EB46A3EC64C4Q40201448-82A4B3B2-A4E0-4C95-97F9-0643921C0610Q40267284-58D4F9BD-7DD6-4429-B48A-5B8BD05111CB
P2860
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@ast
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@en
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@nl
type
label
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@ast
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@en
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@nl
prefLabel
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@ast
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@en
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@nl
P2093
P2860
P356
P1476
Lentivector-mediated RNAi effi ...... vival of scrapie-infected mice
@en
P2093
Alexander Pfeifer
Andreas Hofmann
Gerda Mitteregger
Hans Kretzschmar
Markus Moser
Saba Al-Khadra
Sabina Eigenbrod
Uwe Bertsch
P2860
P304
P356
10.1172/JCI29236
P407
P577
2006-12-01T00:00:00Z